Characterizing Lung Cancer in Li-Fraumeni Syndrome
This cohort study describes lung cancer incidence, diagnosis, and outcome in individuals with Li-Fraumeni syndrome.
This cohort study describes lung cancer incidence, diagnosis, and outcome in individuals with Li-Fraumeni syndrome.
This meta-analysis provides a detailed global prevalence estimate of seborrheic dermatitis, examining variations across different sociodemographic factors and settings.
Explore special articles published online first to coincide with presentations at the European Respiratory Society International Congress.
Meletios Dimopoulos, MD, National and Kapodistrian University of Athens School of Medicine, Athens, Greece, discusses the use of selinexor in the treatment of multiple myeloma,…
The first international consensus guidelines for anal cancer screening of high-risk populations were published in 2024. Given barriers associated with anal swab collection, self-collection may…
Ritu Salani, MD, discusses the development of ADCs, the potential role of selinexor, and the use of PARP inhibitors across endometrial cancer subsets.
An NDA has been submitted to the FDA for TLX101-CDx for the characterization of progressive or recurrent glioma in adult and pediatric patients.
The largest-ever study of women in sub-Saharan Africa zeroes in on the combination of bacterial vaginosis-associated bacteria and inflammatory proteins that raise the risk of…
The FDA has granted fast track designation to IBI363 for unresectable advanced or metastatic melanoma after progression on at least 1 line of therapy.
One resource seems infinite and free: the professionalism of caregivers.
Every doctor I asked told me they, too, were chronically behind and spent a few uncompensated hours outside of work each day catching up on…